JPWO2022109162A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022109162A5 JPWO2022109162A5 JP2023531056A JP2023531056A JPWO2022109162A5 JP WO2022109162 A5 JPWO2022109162 A5 JP WO2022109162A5 JP 2023531056 A JP2023531056 A JP 2023531056A JP 2023531056 A JP2023531056 A JP 2023531056A JP WO2022109162 A5 JPWO2022109162 A5 JP WO2022109162A5
- Authority
- JP
- Japan
- Prior art keywords
- vector system
- domain
- polynucleotides
- vector
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063116611P | 2020-11-20 | 2020-11-20 | |
| US63/116,611 | 2020-11-20 | ||
| PCT/US2021/059931 WO2022109162A1 (en) | 2020-11-20 | 2021-11-18 | Vector system for delivery of multiple polynucleotides and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023551220A JP2023551220A (ja) | 2023-12-07 |
| JPWO2022109162A5 true JPWO2022109162A5 (https=) | 2024-11-25 |
| JP2023551220A5 JP2023551220A5 (https=) | 2024-11-25 |
Family
ID=80112397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023531056A Pending JP2023551220A (ja) | 2020-11-20 | 2021-11-18 | 複数のポリヌクレオチドを送達するためのベクター系およびその使用法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230407330A1 (https=) |
| EP (1) | EP4247963A1 (https=) |
| JP (1) | JP2023551220A (https=) |
| KR (1) | KR20230156687A (https=) |
| CN (1) | CN116745427A (https=) |
| AU (1) | AU2021382654A1 (https=) |
| CA (1) | CA3199588A1 (https=) |
| IL (1) | IL303013A (https=) |
| MX (1) | MX2023005876A (https=) |
| WO (1) | WO2022109162A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2934532B1 (en) | 2012-12-20 | 2019-10-23 | Purdue Research Foundation | Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| JP7282521B2 (ja) | 2016-04-08 | 2023-05-29 | パーデュー・リサーチ・ファウンデイション | Ｃａｒ ｔ細胞療法のための方法および組成物 |
| JP7178355B2 (ja) | 2017-02-28 | 2022-11-25 | エンドサイト・インコーポレイテッド | Ｃａｒ ｔ細胞療法のための組成物および方法 |
| JP7549303B2 (ja) | 2018-01-22 | 2024-09-11 | エンドサイト・インコーポレイテッド | Ｃａｒ ｔ細胞の使用方法 |
| CN112105382A (zh) | 2018-02-23 | 2020-12-18 | 恩多塞特公司 | 用于car t细胞疗法的顺序方法 |
| CN112262214A (zh) | 2018-04-12 | 2021-01-22 | 优莫佳生物制药股份有限公司 | 病毒载体及包装细胞系 |
| US20240122978A1 (en) * | 2019-10-16 | 2024-04-18 | Umoja Biopharma, Inc. | Retroviral vector for univeral receptor therapy |
| EP4448729A1 (en) * | 2021-12-17 | 2024-10-23 | Umoja Biopharma, Inc. | Cytotoxic innate lymphoid cell and uses thereof |
| WO2023240282A1 (en) * | 2022-06-10 | 2023-12-14 | Umoja Biopharma, Inc. | Engineered stem cells and uses thereof |
| JP2025542083A (ja) * | 2022-11-07 | 2025-12-25 | センティ バイオサイエンシズ インコーポレイテッド | キメラタンパク質の細胞表面共局在化のための方法及び組成物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE351916T1 (de) | 1999-10-12 | 2007-02-15 | Pasteur Institut | Lentivirale triplex-dns, und vektoren und rekombinante zellen, die lentivirale triplex-dns enthalten |
| WO2015017214A1 (en) | 2013-07-29 | 2015-02-05 | Bluebird Bio, Inc. | Multipartite signaling proteins and uses thereof |
| GB201503500D0 (en) | 2015-03-02 | 2015-04-15 | Ucl Business Plc | Cell |
| JP7206214B2 (ja) * | 2016-12-13 | 2023-01-17 | シアトル チルドレンズ ホスピタル （ディービーエイ シアトル チルドレンズ リサーチ インスティテュート） | インビトロ及びインビボで操作された細胞において発現された化学誘導シグナル伝達複合体の外因性薬物活性化の方法 |
| CN112262214A (zh) * | 2018-04-12 | 2021-01-22 | 优莫佳生物制药股份有限公司 | 病毒载体及包装细胞系 |
| CA3091490A1 (en) * | 2018-04-27 | 2019-10-31 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Rapamycin resistant cells |
-
2021
- 2021-11-18 CA CA3199588A patent/CA3199588A1/en active Pending
- 2021-11-18 MX MX2023005876A patent/MX2023005876A/es unknown
- 2021-11-18 AU AU2021382654A patent/AU2021382654A1/en active Pending
- 2021-11-18 JP JP2023531056A patent/JP2023551220A/ja active Pending
- 2021-11-18 EP EP21844083.2A patent/EP4247963A1/en active Pending
- 2021-11-18 IL IL303013A patent/IL303013A/en unknown
- 2021-11-18 CN CN202180090375.XA patent/CN116745427A/zh active Pending
- 2021-11-18 US US18/037,986 patent/US20230407330A1/en active Pending
- 2021-11-18 WO PCT/US2021/059931 patent/WO2022109162A1/en not_active Ceased
- 2021-11-18 KR KR1020237020555A patent/KR20230156687A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024100972A5 (https=) | ||
| US12163169B2 (en) | Inducible chimeric cytokine receptors | |
| Cappell et al. | A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains | |
| JP2021520853A5 (https=) | ||
| KR102805003B1 (ko) | 종양 특이적 t 세포 면역요법을 위한 il-13 수용체 알파 2 (il13ra2) 키메라 항원 수용체 | |
| US12280119B2 (en) | Chimeric transmembrane proteins and uses thereof | |
| JP2020501605A5 (https=) | ||
| Tang et al. | The challenges and molecular approaches surrounding interleukin-2-based therapeutics in cancer | |
| AU2021203626B2 (en) | Chimeric polypeptides and methods of altering their localisation in the cell membrane | |
| CN112368298A (zh) | 嵌合跨膜蛋白及其用途 | |
| JPWO2022109162A5 (https=) | ||
| EP3609914A1 (en) | Chimeric antigen receptor t cells targeting the tumor microenvironment | |
| CN105683214A (zh) | 触发针对多种肿瘤的抗体依赖细胞毒性的嵌合受体 | |
| KR102822623B1 (ko) | T-세포 악성 종양의 면역요법을 위한 cd2 표면 발현 및 키메라 항원 수용체의 발현에 대한 차단 | |
| CN110257338A (zh) | 嵌合细胞因子受体 | |
| JP2022535410A (ja) | Ｔａｃｉを標的とする抗体及びキメラ抗原受容体 | |
| CN114286691A (zh) | Cs1-抗体和抗cs1-car-t细胞 | |
| WO2021087205A1 (en) | Chimeric receptor sensors | |
| Lin et al. | Idecabtagene vicleucel: the first BCMA-targeted CAR-T cell therapy for multiple myeloma | |
| JP2025540251A (ja) | 血液癌の治療において使用するためのキット | |
| CN119790072A (zh) | 用于刺激哺乳动物的嵌合抗原受体介导的免疫反应的方法中的针对cd123的靶向模块 | |
| WO2026042055A1 (en) | Dual targeting cancer cell therapy for cd19 and cd20 | |
| RU2826155C2 (ru) | Индуцибельные химерные цитокиновые рецепторы | |
| Golubovskaya et al. | Major highlights of the CAR-TCR Summit, Boston, 2016 | |
| CN118240777A (zh) | 细胞组合物及其应用和药物 |